Skip to main content
OpenTrials
Completed

NCT Number: NCT00092326

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)

The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The duration of treatment is 24 hours.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Impaction of a molar tooth requiring removal

Exclusion criteria

  • Any known allergy to the study drugs

Treatment and study plan

MK0966, rofecoxib

Drug

Comparator: oxycodone with acetaminophen, placebo

Drug

Primary outcomes

  1. Post-op dental pain over 6 hours as measured by pain intensity/relief scores, patient global assessment, and time to perceptible/meaningful pain relief.

Secondary outcomes

  1. Time to onset of analgesic effect, peak analgesic effect, and/or duration of analgesic effect over 24 hours.

Sponsors and collaborators

Lead sponsor

Merck Sharp & Dohme LLC

Industry

Registry information

Official study title

A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Study to Evaluate the Efficacy of Rofecoxib and a Dosing Regimen of Oxycodone With Acetaminophen Over 24 Hours in Patients With Postoperative Dental Pain

Important dates

Study start
2002
Primary completion
2002
Study completion
2002
First posted
Sep 27, 2004
Registry last updated
Feb 22, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.